Diagnosis of IBD involves a combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can help align national and international experts and teams to provide accurate diagnoses and treatment regimens. Treatment regimens for IBD involve individualized development, typically including drug therapy, rehabilitation interventions, and regular follow-up visits.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored throughout the treatment process, and timely adjusted according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of IBD accompanying movement.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.